Mihai Cirstea1, Keith R Walley2, James A Russell2, Liam R Brunham2, Kelly R Genga2, John H Boyd2. 1. Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: mihai.cirstea@hli.ubc.ca. 2. Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract
PURPOSE: We sought to determine whether an early high-density lipoprotein cholesterol (HDL-C) measurement at emergency department (ED) admission is prognostic of multiorgan dysfunction syndrome (MODS) and death in a suspected sepsis cohort. MATERIALS AND METHODS: Two hundred patients with clinically suspected sepsis were recruited at admission to our tertiary care hospital's ED. Lipids were measured at the time of first ED blood draw. Clinical data were collected via chart review. Primary outcomes of interest were development of MODS and 28-day mortality. Secondary outcomes included need for critical care, single-organ failures, days alive and free of vasopressor and ventilator support, and 90-day mortality. RESULTS: High-density lipoprotein cholesterol was greatly decreased in patients who developed MODS and/or died and remained stable over the first week of admission. Receiver operator characteristic analysis demonstrated that HDL-C had superior predictive ability compared with all routine clinical markers for both development of MODS and 28-day mortality, and identified an HDL-C cutoff of 25.1 mg/dL below which patients were at significantly greater risk for development of all adverse outcomes. CONCLUSIONS: Plasma HDL-C level was characterized by early decrease and high stability, and was the best prognostic marker for adverse outcomes in a suspected sepsis cohort.
PURPOSE: We sought to determine whether an early high-density lipoprotein cholesterol (HDL-C) measurement at emergency department (ED) admission is prognostic of multiorgan dysfunction syndrome (MODS) and death in a suspected sepsis cohort. MATERIALS AND METHODS: Two hundred patients with clinically suspected sepsis were recruited at admission to our tertiary care hospital's ED. Lipids were measured at the time of first ED blood draw. Clinical data were collected via chart review. Primary outcomes of interest were development of MODS and 28-day mortality. Secondary outcomes included need for critical care, single-organ failures, days alive and free of vasopressor and ventilator support, and 90-day mortality. RESULTS: High-density lipoprotein cholesterol was greatly decreased in patients who developed MODS and/or died and remained stable over the first week of admission. Receiver operator characteristic analysis demonstrated that HDL-C had superior predictive ability compared with all routine clinical markers for both development of MODS and 28-day mortality, and identified an HDL-C cutoff of 25.1 mg/dL below which patients were at significantly greater risk for development of all adverse outcomes. CONCLUSIONS: Plasma HDL-C level was characterized by early decrease and high stability, and was the best prognostic marker for adverse outcomes in a suspected sepsis cohort.
Authors: Auguste Dargent; Jean-Paul Pais de Barros; Samir Saheb; Randa Bittar; Wilfried Le Goff; Alain Carrié; Thomas Gautier; Isabelle Fournel; Anne Laure Rerole; Hélène Choubley; David Masson; Laurent Lagrost; Jean-Pierre Quenot Journal: J Lipid Res Date: 2020-10-09 Impact factor: 5.922
Authors: Daniel A Hofmaenner; Anna Kleyman; Adrian Press; Michael Bauer; Mervyn Singer Journal: Am J Respir Crit Care Med Date: 2022-02-15 Impact factor: 30.528
Authors: Loren E Smith; Derek K Smith; Jeffrey D Blume; MacRae F Linton; Frederic T Billings Journal: J Am Heart Assoc Date: 2017-12-09 Impact factor: 5.501
Authors: Sébastien Tanaka; Julien Labreuche; Elodie Drumez; Anatole Harrois; Sophie Hamada; Bernard Vigué; David Couret; Jacques Duranteau; Olivier Meilhac Journal: Ann Intensive Care Date: 2017-06-06 Impact factor: 6.925
Authors: Andreas Hohn; Ivan Iovino; Fabrizio Cirillo; Hendrik Drinhaus; Kathrin Kleinbrahm; Lennert Boehm; Edoardo De Robertis; Jochen Hinkelbein Journal: Biomed Res Int Date: 2018-03-21 Impact factor: 3.411